20Jun GlaxoSmithKline Pharmaceuticals informPursuant to Regulation 30 read with para A of Part A of Schedule III of..
15May GlaxoSmithKline Pharmaceuticals informIn compliance with the provisions of Regulation 24A of SEBI LODR Amendme..
15May GlaxoSmithKline Pharmaceuticals informPursuant to Regulation 47 of the Listing Obligations and Disclosure Requ..
15May GlaxoSmithKline Pharmaceuticals informPursuant to Regulation 30(6) of Schedule III, of the Listing Obligations..
13May GlaxoSmithKline Pharmaceuticals informGlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board..